Letter to the editor
Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency

https://doi.org/10.1016/j.jaci.2014.10.010Get rights and content
Under a Creative Commons license
open access

Cited by (0)

Supported by the Research Foundation Flanders (FWO), the VIB, and the European Research Council grant IMMUNO. I.M. is supported by a KOF mandate of the KU Leuven, Belgium, and by the Jeffrey Modell Foundation.

Disclosure of potential conflict of interest: L. Van Eyck has received research support from Research Foundation Flanders (FWO) and is employed by University Hospital Leuven. M. S. Hershfield has consultant arrangements with and has received research support from Sigma-Tau Pharmaceuticals and has a patent with and receives royalties from Creata Pharmaceuticals. D. Pombal is employed by VIB. G. Frans has received a GOA grant from the Catholic University of Leuven, Belgium. H. Schaballie has received research support from Research Foundation Flanders (FWO). J. Dooley has received research support from the European Research Council. X. Bossuyt has received research support from the Research Council of Catholic University Leuven. A. Liston has received research support from the European Research Council, Research Foundation Flanders (FWO), and VIB. The rest of the authors declare that they have no relevant conflicts of interest.

These authors equally contributed to this work as senior authors.